- Home
- About
- Find staff
- Sofie Johansson Alm
Sofie Johansson Alm
Doctoral Student
Department of Laboratory Medicine-
Comparison of RNA- and DNA-based methods for measurable residual disease analysis in NPM1-mutated acute myeloid
leukemia
L. Pettersson, Sofie J. Alm, A. Almstedt, Y. L. Chen, G. Orrsjo, G. Shah-Barkhordar, L. Zhou, H. Kotarsky, K. Vidovic, Julia Asp, V. Lazarevic, L. H. Saal, Linda Fogelstrand, M. Ehinger
International Journal of Laboratory Hematology - 2021 -
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid
leukaemia
K. L. Juul-Dam, H. B. Ommen, C. G. Nyvold, C. Walter, H. Vålerhaugen, V. Kairisto, Jonas Abrahamsson, Sofie J. Alm, K. Jahnukainen, B. Lausen, D. Reinhardt, B. Zeller, N. von Neuhoff, Linda Fogelstrand, H. Hasle
British Journal of Haematology - 2020 -
Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in
AML.
Erik Malmberg, Sofie J. Alm, Malin Nicklasson, Vladimir Lazarevic, Sara Ståhlman, Tore Samuelsson, Stig Lenhoff, Julia Asp, Mats Ehinger, Lars Palmqvist, Mats Brune, Linda Fogelstrand
Leukemia & lymphoma - 2019 -
Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid
Leukemia
KL Juul-Dam, HB Ommen, C Guldborg Nyvold, C Walter, H Vålerhaugen, V Kairisto, Jonas Abrahamsson, Sofie J. Alm, Kirsi Jahnukainen, Birgitte Lausen, D Reinhardt, B Zellee, N von Neuhoff, Linda Fogelstrand, Henrik Hasle
Blood. 132 (Supplement 1): 2754. - 2018 -
Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow
cytometry.
Sofie J. Alm, C Engvall, Julia Asp, Lars Palmqvist, Jonas Abrahamsson, Linda Fogelstrand
International journal of laboratory hematology - 2017 -
Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next generation
sequencing.
Erik Malmberg, Sara Ståhlman, Anna Rehammar, Tore Samuelsson, Sofie J. Alm, Erik Kristiansson, Jonas Abrahamsson, Hege Garelius, Louise Pettersson, Mats Ehinger, Lars Palmqvist, Linda Fogelstrand
European journal of haematology - 2017 -
Patient-Tailored Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Next Generation
Sequencing
Erik Malmberg, Sara Ståhlman, Anna Rehammar, Tore Samuelsson, Sofie J. Alm, Erik Kristiansson, Jonas Abrahamsson, Garelius Hege, Lars Palmqvist, Linda Fogelstrand
Blood. 57th ASH Annual Meeting and Exposition. Orlando, FL, USA. December 5-8, 2015 - 2015 -
Minimal Residual Disease Monitoring in Childhood Precursor B Lymphoblastic Leukemia with t(12;21)(p13;q22); ETV6-RUNX1: A Comparison Between Quantitative RT-PCR and Flow
Cytometry
Sofie J. Alm, Charlotte Engvall, Julia Asp, Lars Palmqvist, Jonas Abrahamsson, Linda Fogelstrand
Blood. 56th ASH Annual Meeting and Exposition. Orlando, FL, USA. December 5-8, 2014 - 2014